Recruiting Geographic Atrophy Studies in Shelby
About Geographic Atrophy Clinical Trials in Shelby
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 2 geographic atrophy clinical trials recruiting participants in Shelby, NC. These studies are seeking a combined 65 participants. Research is being sponsored by ADARx Pharmaceuticals, Inc., Biohaven Therapeutics Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in Shelby — FAQ
Are there geographic atrophy clinical trials in Shelby?
Yes, there are 2 geographic atrophy clinical trials currently recruiting in Shelby, NC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Shelby?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Shelby research site will contact you about next steps.
Are clinical trials in Shelby free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Shelby studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 2 active trials in Shelby are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated October 16, 2026 from ClinicalTrials.gov